{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:17:09Z","timestamp":1793362629081,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T00:00:00Z","timestamp":1596585600000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005492","name":"Stanford University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016667","name":"Sean N. Parker Center for Allergy and Asthma Research, Stanford University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016667","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["worldallergyorganizationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Allergy Organization Journal"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.waojou.2020.100455","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T09:33:53Z","timestamp":1600421633000},"page":"100455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Oral immunotherapy for peanut allergy: The pro argument"],"prefix":"10.1016","volume":"13","author":[{"given":"R. Sharon","family":"Chinthrajah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Dunham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanitha","family":"Sampath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharad","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayantani","family":"Sindher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Nadeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.waojou.2020.100455_bib1","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.3390\/ijerph15092043","article-title":"The epidemiology of food allergy in the global context","volume":"15","author":"Loh","year":"2018","journal-title":"Int J Environ Res Publ Health"},{"key":"10.1016\/j.waojou.2020.100455_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.5630","article-title":"Prevalence and severity of food allergies among US adults","volume":"2","author":"Gupta","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.waojou.2020.100455_bib3","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-1235","article-title":"The public health impact of parent-reported childhood food allergies in the United States","volume":"142","author":"Gupta","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.waojou.2020.100455_bib4","first-page":"S428","article-title":"The economic impact of peanut allergies","volume":"24","author":"Cannon","year":"2018","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.waojou.2020.100455_bib5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1024\/0300-9831\/a000055","article-title":"Allergic reactions to food proteins","volume":"81","author":"Ballmer-Weber","year":"2011","journal-title":"Int J Vitam Nutr Res"},{"key":"10.1016\/j.waojou.2020.100455_bib6","series-title":"Blue Cross Blue Shield. Childhood Allergies in America","year":"2018"},{"key":"10.1016\/j.waojou.2020.100455_bib7","first-page":"165","article-title":"Food-induced anaphylaxis","volume":"32","author":"Cianferoni","year":"2012","journal-title":"Immunol Allergy Clin"},{"key":"10.1016\/j.waojou.2020.100455_bib8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000375417","article-title":"Peanut and tree nut allergy","volume":"101","author":"Cox","year":"2015","journal-title":"Chem Immunol Allergy"},{"key":"10.1016\/j.waojou.2020.100455_bib9","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.alit.2017.02.001","article-title":"Japanese guidelines for food allergy 2017","volume":"66","author":"Ebisawa","year":"2017","journal-title":"Allergol Int"},{"key":"10.1016\/j.waojou.2020.100455_bib10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jaip.2019.06.037","article-title":"Deficits and opportunities in allergists' approaches to food allergy-related bullying","volume":"8","author":"Bingemann","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2020.100455_bib11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s12016-018-8708-x","article-title":"Beyond avoidance: the psychosocial impact of food allergies","volume":"57","author":"Feng","year":"2019","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.waojou.2020.100455_bib13","first-page":"55","article-title":"Oral immunotherapy for food allergy","volume":"36","author":"Burbank","year":"2016","journal-title":"Immunol Allergy Clin"},{"key":"10.1016\/j.waojou.2020.100455_bib14","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jaci.2011.10.023","article-title":"The safety and efficacy of sublingual and oral immunotherapy for milk allergy","volume":"129","author":"Keet","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100455_bib15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.18176\/jiaci.0143","article-title":"Oral immunotherapy for food allergy","volume":"27","author":"Wood","year":"2017","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100455_bib16","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa1812856","article-title":"AR101 oral immunotherapy for peanut allergy","volume":"379","author":"Vickery","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.waojou.2020.100455_bib17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jaip.2017.05.006","article-title":"Quantitative assessment of the safety benefits associated with increasing clinical peanut thresholds through immunotherapy","volume":"6","author":"Baumert","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2020.100455_bib18","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/all.13124","article-title":"Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis","volume":"72","author":"Nurmatov","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2020.100455_bib19","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jaip.2018.10.048","article-title":"Efficacy, safety, and quality of life in a multicenter, randomized, placebo-controlled trial of low-dose peanut oral immunotherapy in children with peanut allergy","volume":"7","author":"Blumchen","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2020.100455_bib20","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jaci.2010.12.1111","article-title":"A\u00a0randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response","volume":"127","author":"Varshney","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100455_bib21","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0140-6736(19)31793-3","article-title":"Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study","volume":"394","author":"Chinthrajah","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.waojou.2020.100455_bib22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaci.2016.05.027","article-title":"Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective","volume":"139","author":"Vickery","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100455_bib23","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.jaip.2019.01.022","article-title":"Changing patient mindsets about non-life-threatening symptoms during oral immunotherapy: a randomized clinical trial","volume":"7","author":"Howe","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2020.100455_bib24","doi-asserted-by":"crossref","first-page":"100010","DOI":"10.1016\/j.waojou.2018.11.008","article-title":"The safety of oral immunotherapy for food allergy during maintenance phase: effect of counselling on adverse reactions","volume":"12","author":"Arasi","year":"2019","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.waojou.2020.100455_bib25","series-title":"Allergenic Products Advisory Committee September 13, 2019 Meeting Announcement","year":"2019"},{"key":"10.1016\/j.waojou.2020.100455_bib26","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.annemergmed.2006.01.018","article-title":"Second symposium on the definition and management of anaphylaxis: summary report--second national Institute of allergy and infectious disease\/food allergy and anaphylaxis network symposium","volume":"47","author":"Sampson","year":"2006","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.waojou.2020.100455_bib27","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1398-9995.2007.01421.x","article-title":"The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology","volume":"62","author":"Muraro","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2020.100455_bib28","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/S0140-6736(19)30420-9","article-title":"Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety","volume":"393","author":"Chu","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.waojou.2020.100455_bib29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13601-015-0055-x","article-title":"Accidental exposures to peanut in a large cohort of Canadian children with peanut allergy","volume":"5","author":"Cherkaoui","year":"2015","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.waojou.2020.100455_bib30","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1016\/j.jaip.2019.04.010","article-title":"First real-world safety analysis of preschool peanut oral immunotherapy","volume":"7","author":"Soller","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2020.100455_bib31","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/all.13330","article-title":"The longitudinal impact of probiotic and peanut oral immunotherapy on health-related quality of life","volume":"73","author":"Dunn Galvin","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2020.100455_bib32","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/all.12441","article-title":"EAACI food allergy and anaphylaxis guidelines: managing patients with food allergy in the community","volume":"69","author":"Muraro","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2020.100455_bib33","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jaip.2018.06.016","article-title":"Quality of life of food-allergic patients before, during, and after oral immunotherapy","volume":"7","author":"Epstein-Rigbi","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2020.100455_bib34","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/pai.13066","article-title":"Parent and child perception of quality of life in a randomized controlled peanut oral immunotherapy trial","volume":"30","author":"Reier-Nilsen","year":"2019","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.waojou.2020.100455_bib35","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jaci.2009.03.045","article-title":"Safety of a peanut oral immunotherapy protocol in children with peanut allergy","volume":"124","author":"Hofmann","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100455_bib36","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jaci.2009.05.022","article-title":"Clinical efficacy and immune regulation with peanut oral immunotherapy","volume":"124","author":"Jones","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100455_bib37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jaci.2010.04.030","article-title":"Oral peanut immunotherapy in children with peanut anaphylaxis","volume":"126","author":"Blumchen","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100455_bib38","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1365-2222.2011.03699.x","article-title":"Efficacy and safety of high-dose peanut oral immunotherapy with factors predicting outcome","volume":"41","author":"Anagnostou","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.waojou.2020.100455_bib39","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jaci.2013.09.046","article-title":"A\u00a0pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients","volume":"132","author":"Schneider","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100455_bib40","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jaci.2013.11.007","article-title":"Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy","volume":"133","author":"Vickery","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100455_bib41","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0140-6736(13)62301-6","article-title":"Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial","volume":"383","author":"Anagnostou","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.waojou.2020.100455_bib42","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaci.2014.11.034","article-title":"Administration of a probiotic with peanut oral immunotherapy: a randomized trial","volume":"135","author":"Tang","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100455_bib43","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jaci.2016.08.010","article-title":"Omalizumab facilitates rapid oral desensitization for peanut allergy","volume":"139","author":"MacGinnitie","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100455_bib44","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/apa.13668","article-title":"Double-blind placebo-controlled challenge showed that peanut oral immunotherapy was effective for severe allergy without negative effects on airway inflammation","volume":"106","author":"Kukkonen","year":"2017","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.waojou.2020.100455_bib45","doi-asserted-by":"crossref","unstructured":"Hsiao K-C, Ponsonby A-L, Axelrad C, et\u00a0al. Long-term clinical and immunological effects of probiotic and peanut oral immunotherapy after treatment cessation: 4-year follow-up of a randomised, double-blind, placebo-controlled trial. The Lancet Child & Adolescent Health;1:97-105.","DOI":"10.1016\/S2352-4642(17)30041-X"},{"key":"10.1016\/j.waojou.2020.100455_bib46","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jaip.2017.09.016","article-title":"Efficacy and safety of AR101 in oral immunotherapy for peanut allergy: results of ARC001, a randomized, double-blind, placebo-controlled phase 2 clinical trial","volume":"6","author":"Bird","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2020.100455_bib47","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000486310","article-title":"Oral immunotherapy in Japanese children with anaphylactic peanut allergy","volume":"175","author":"Nagakura","year":"2018","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.waojou.2020.100455_bib48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1710-1492-10-25","article-title":"Multiple-allergen oral immunotherapy improves quality of life in caregivers of food-allergic pediatric subjects","volume":"10","author":"Otani","year":"2014","journal-title":"Allergy Asthma Clin Immunol"}],"container-title":["World Allergy Organization Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455120303586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455120303586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:42:43Z","timestamp":1761849763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939455120303586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1939455120303586"],"URL":"https:\/\/doi.org\/10.1016\/j.waojou.2020.100455","relation":{},"ISSN":["1939-4551"],"issn-type":[{"value":"1939-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral immunotherapy for peanut allergy: The pro argument","name":"articletitle","label":"Article Title"},{"value":"World Allergy Organization Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.waojou.2020.100455","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.waojou.2020.100445","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc. on behalf of World Allergy Organization.","name":"copyright","label":"Copyright"}],"article-number":"100455"}}